These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 2183254

  • 1. The antiobsessional effects of clomipramine do not require concomitant affective disorder.
    Katz RJ, DeVeaugh-Geiss J.
    Psychiatry Res; 1990 Feb; 31(2):121-9. PubMed ID: 2183254
    [Abstract] [Full Text] [Related]

  • 2. Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.
    Mavissakalian M, Turner SM, Michelson L, Jacob R.
    Am J Psychiatry; 1985 May; 142(5):572-6. PubMed ID: 3885761
    [Abstract] [Full Text] [Related]

  • 3. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J, Landau P, Katz R.
    Psychopharmacol Bull; 1989 May; 25(1):36-40. PubMed ID: 2672070
    [Abstract] [Full Text] [Related]

  • 4. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.
    Thorén P, Asberg M, Cronholm B, Jörnestedt L, Träskman L.
    Arch Gen Psychiatry; 1980 Nov; 37(11):1281-5. PubMed ID: 7436690
    [Abstract] [Full Text] [Related]

  • 5. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R.
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [Abstract] [Full Text] [Related]

  • 6. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M.
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [Abstract] [Full Text] [Related]

  • 7. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J, Insel TR.
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [Abstract] [Full Text] [Related]

  • 8. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J, Katz R, Landau P, Goodman W, Rasmussen S.
    Psychopharmacol Bull; 1990 Jun; 26(1):54-9. PubMed ID: 2196627
    [Abstract] [Full Text] [Related]

  • 9. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 10. Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder.
    Austin LS, Lydiard RB, Ballenger JC, Cohen BM, Laraia MT, Zealberg JJ, Fossey MD, Ellinwood EH.
    Biol Psychiatry; 1991 Aug 01; 30(3):225-32. PubMed ID: 1832972
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J, Pecknold JC, van den Steen N, Engelsmann F.
    Prog Neuropsychopharmacol; 1981 Aug 01; 5(3):257-62. PubMed ID: 7022517
    [No Abstract] [Full Text] [Related]

  • 12. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM.
    Br J Psychiatry; 1992 Nov 01; 161():665-70. PubMed ID: 1422616
    [Abstract] [Full Text] [Related]

  • 13. Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.
    Fallon BA, Liebowitz MR, Campeas R, Schneier FR, Marshall R, Davies S, Goetz D, Klein DF.
    Arch Gen Psychiatry; 1998 Oct 01; 55(10):918-24. PubMed ID: 9783563
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clomipramine in obsessive-compulsive disorder.
    Katz RJ, DeVeaugh-Geiss J, Landau P.
    Biol Psychiatry; 1990 Sep 01; 28(5):401-14. PubMed ID: 2207219
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
    Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL.
    Arch Gen Psychiatry; 1988 Feb 01; 45(2):167-72. PubMed ID: 3276283
    [Abstract] [Full Text] [Related]

  • 17. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL, Swedo SE, Rapoport JL, Koby EV, Lenane MC, Cheslow DL, Hamburger SD.
    Arch Gen Psychiatry; 1989 Dec 01; 46(12):1088-92. PubMed ID: 2686576
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL.
    Am J Psychiatry; 1988 Dec 01; 145(12):1521-5. PubMed ID: 3057923
    [Abstract] [Full Text] [Related]

  • 20. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Mellström B, Linnoila M.
    Arch Gen Psychiatry; 1985 Oct 01; 42(10):977-83. PubMed ID: 3899048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.